SUCRALFATE

Post-LOE

sucralfate

Teva

ANDAORALTABLET

Approved

Mar 1996

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

SUCRALFATE (sucralfate) by Teva. Approved for aluminum complex [epc]. First approved in 1996.

Drug data last refreshed 10h ago

Mechanism of Action

Pharmacologic Class:

Aluminum Complex

Indications (1)

Aluminum Complex

Company

Worked on SUCRALFATE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.